<!-- START OF HEADER -->
<HTML><HEAD>
<TITLE> EMBASSY: SIGSCAN documentation. </TITLE>
</HEAD>
<BODY BGCOLOR="#FFFFFF" text="#000000">

<table align=center border=0 cellspacing=0 cellpadding=0>
<tr><td valign=top>
<A HREF="/" ONMOUSEOVER="self.status='Go to the EMBOSS home page';return true"><img border=0 src="emboss_icon.jpg" alt="" width=150 height=48></a>
</td>
<td align=left valign=middle>
<b><font size="+6">

<H2> sigscan documentation
</font></b>
</td></tr>
</table>
<br>&nbsp;
<p>



<!-- END OF HEADER -->




<!-- CONTENTS
     This always includes the sections below.
     Other subsections can be added for individual applications.
-->
<H2>CONTENTS </H2>
<b> <a href="#1.0">1.0     SUMMARY                   </a></b><br>
<b> <a href="#2.0">2.0     INPUTS & OUTPUTS          </a></b><br>
<b> <a href="#3.0">3.0     INPUT FILE FORMAT         </a></b><br>
<b> <a href="#4.0">4.0     OUTPUT FILE FORMAT        </a></b><br>
<b> <a href="#5.0">5.0     DATA FILES                </a></b><br>
<b> <a href="#6.0">6.0     USAGE                     </a></b><br>    
<b> <a href="#7.0">7.0     KNOWN BUGS & WARNINGS     </a></b><br>    
<b> <a href="#8.0">8.0     NOTES                     </a></b><br>
<b> <a href="#9.0">9.0     DESCRIPTION               </a></b><br>
<b> <a href="#10.0">10.0   ALGORITHM                 </a></b><br>
<b> <a href="#11.0">11.0   RELATED APPLICATIONS      </a></b><br>
<b> <a href="#12.0">12.0   DIAGNOSTIC ERROR MESSAGES </a></b><br>
<b> <a href="#13.0">13.0   AUTHORS                   </a></b><br>
<b> <a href="#14.0">14.0   REFERENCES                </a></b><br>


<!-- SUMMARY
     Succint description of the application, particularly its inputs, outputs
     and what it does.  The same text is given at the top of the source (.c)
     file and in the <documentation> attribute of the <application definition>
     of the ACD file.
-->
<a name="1.0"></a>
<br><br><br><H2> 1.0   SUMMARY  </H2>
Generates a DHF (domain hits file) of hits (sequences) from scanning a signature against a sequence database.
Generate hits (DHF file) from a signature search



<!-- INPUTS & OUTPUTS
     Short summary of the application inputs and outputs in its different 
     modes of usage (if appropriate). More detail than the summary.
-->
<a name="2.0"></a>
<br><br><br><H2> 2.0   INPUTS & OUTPUTS          </H2>
SIGSCAN reads a signature from a protein signature file, scans the signature against a protein sequence database and generates a DHF file (domain hits file) of hits to database sequences and a DAF file (domain alignment file) of corresponding signature-sequence alignments. The names of the signature file, DHF file and DAF file are provided by the user. The user specifies a maximum number of high-scoring hits that will be generated.


<!-- INPUT FILE FORMAT 
     Description and example(s) of input file formats.  Should provide enough
     information to write and parse the file.  Should describe the format in 
     unusual cases - null input, etc.
     Use "<b>sigscan</b> reads any normal sequence USAs." if
     appropriate.
-->



<a name="3.0"></a>
<br><br><br><H2> 3.0   INPUT FILE FORMAT         </H2>
The format of the signature file is described in <a href="siggen.html">SIGGEN documentation</a>.


<a name="input.1"></a>
<h3>Input files for usage example </h3>
<p><h3>File: ../siggen-keep/54894.sig</h3>
<table width="90%"><tr><td bgcolor="#FFCCFF">
<pre>
TY   SCOP
XX
TS   1D
XX
CL   Alpha and beta proteins (a+b)
XX
FO   Ferredoxin-like
XX
SF   Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain
XX
FA   Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain
XX
SI   54894
XX
NP   15
XX
NN   [1]
XX
IN   NRES 1 ; NGAP 1 ; WSIZ 0
XX
AA   H ; 2
XX
GA   12 ; 2
XX
NN   [2]
XX
IN   NRES 1 ; NGAP 1 ; WSIZ 0
XX
AA   P ; 2
XX
GA   1 ; 2
XX
NN   [3]
XX
IN   NRES 1 ; NGAP 1 ; WSIZ 0
XX
AA   P ; 2
XX
GA   26 ; 2
XX
NN   [4]
XX
IN   NRES 1 ; NGAP 1 ; WSIZ 0
XX
AA   F ; 2
XX
GA   16 ; 2
XX
NN   [5]
XX


<font color=red>  [Part of this file has been deleted for brevity]</font>

XX
GA   4 ; 2
XX
NN   [10]
XX
IN   NRES 1 ; NGAP 1 ; WSIZ 0
XX
AA   D ; 2
XX
GA   2 ; 2
XX
NN   [11]
XX
IN   NRES 1 ; NGAP 1 ; WSIZ 0
XX
AA   N ; 2
XX
GA   0 ; 2
XX
NN   [12]
XX
IN   NRES 1 ; NGAP 1 ; WSIZ 0
XX
AA   Y ; 2
XX
GA   0 ; 2
XX
NN   [13]
XX
IN   NRES 1 ; NGAP 1 ; WSIZ 0
XX
AA   G ; 2
XX
GA   3 ; 2
XX
NN   [14]
XX
IN   NRES 1 ; NGAP 1 ; WSIZ 0
XX
AA   P ; 2
XX
GA   3 ; 2
XX
NN   [15]
XX
IN   NRES 1 ; NGAP 1 ; WSIZ 0
XX
AA   P ; 2
XX
GA   2 ; 2
//
</pre>
</td></tr></table><p>
<p><h3>File: swsmall</h3>
<table width="90%"><tr><td bgcolor="#FFCCFF">
<pre>
&gt; Q9WVI4
DDVTMLFSDIVGFTAICAQCTPMQVISMLNELYTRFDHQCGFLDIYKVETIGDAYCVASG
LHRKSLCHAKPIALMALKMMELSEEVLTPDGRPIQMRIGIHSGSVLAGVVGVRMPRYCLF
GNNVTLASKFESGSHPRRINISPTTYQLL
&gt; Q9ERL9
VTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLH
RESDTHAVQIALMALKMMELSNEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGN
NVTLANKFESCSVPRKINVSPTTYRLLKDCPG
&gt; Q9DGG6
EQVSILFADIVGFTKMSANKSAHALVGLLNDLFGRFDRLCEDTKCEKISTLGDCYYCVAG
CPEPRADHAYCCIEMGLGMIKAIEQFCQEKKEMVNMRVGVHTGTVLCGILGMRRFKFDVW
SNDVNLANLMEQLGVAGKVHISEATAKYLDDRYEMEDGKVTERVGQSAVADQLKGLKTYL
I
&gt; Q99396
KELADPVTLIFTDIESSTAQWATQPELMPDAVATHHSMVRSLIENYDCYEVKTVGDSFMI
ACKSPFAAVQLAQELQLRFLRLDWGTTVFDEFYREFEERHAEEGDGKYKPPTARLDPEVY
RQLWNGLRVRVGIHTGLCDIRYDEVTKGYDYYGQTANTAARTESVGNGGQVLMTCETYHS
LSTAERSQFDVTPLGGVPLRGVSEPVEVYQLN
&gt; Q99280
NDSAPKEPTGPVTLIFTDIESSTALWAAHPDLMPDAVATHHRLIRSLITRYECYEVKTVG
DSFMIASKSPFAAVQLAQELQLRFLRLDWETNALDESYREFEEQRAEGECEYTPPTAHMD
PEVYSRLWNGLRVRVGIHTGLCDIRYDEVTKGYDYYGRTSNMAARTESVANGGQVLMTHA
AYMSLSGEDRNQLDVTTLGATVLRGVPEPVRMYQLN
&gt; Q99279
NNNRAPKEPTDPVTLIFTDIESSTALWAAHPDLMPDAVAAHHRMVRSLIGRYKCYEVKTV
GDSFMIASKSPFAAVQLAQELQLCFLHHDWGTNALDDSYREFEEQRAEGECEYTPPTAHM
DPEVYSRLWNGLRVRVGIHTGLCDIIRHDEVTKGYDYYGRTPNMAARTESVANGGQVLMT
HAAYMSLSAEDRKQIDVTALGDVALRGVSDPVKMYQLN
&gt; Q91WF3
VCVLFASVPDFKEFYSESNINHEGLECLRLLNEIIADFDELLSKPKFSGVEKIKTIGSTY
MAATGLNATSGQDTQQDSERSCSHLGTMVEFAVALGSKLGVINKHSFNNFRLRVGLNHGP
VVAGVIGAQKPQYDIWGNTVNVASRMESTGVLGKIQVTEETARAL
&gt; Q91WF3
FHSLYVKRHQGVSVLYADIVGFTRLASECSPKELVLMLNELFGKFDQIAKEHECMRIKIL
GDCYYCVSGLPLSLPDHAINCVRMGLDMCRAIRKLRVATGVDINMRVGVHSGSVLCGVIG
LQKWQYDVWSHDVTLANHMEAGGVPGRVHITGATLALL
&gt; Q8VHH7
NNFMLRIGMNKGGVLAGVIGARKPHYDIWGNTVNVASRMESTGVMGNIQVVEET
&gt; Q8VHH7
FNTMYMYRHENVSILFADIVGFTQLSSACSAQELVKLLNELFARFDKLAAKYHQLRIKIL
GDCYYCICGLPDYREDHAVCSILMGLAMVEAISYVREKTKTGVDMRVGVHTGTVLGGVLG
QKRWQYDVWSTDVTVANKMEAGGIPGRVHISQSTMDCLKGEFDVEPGDGGSRCDYLDEKG
IETYLI
&gt; Q8NFM4
VCVLFASVPDFKEFYSESNINHEGLECLRLLNEIIADFDELLSKPKFSGVEKIKTIGSTY
MAATGLNATSGQDAQQDAERSCSHLGTMVEFAVALGSKLDVINKHSFNNFRLRVGLNHGP
VVAGVIGAQKPQYDIWGNTVNVASRMESTGVLGKIQVTEET
&gt; Q8NFM4
FHSLYVKRHQGVSVLYADIVGFTRLASECSPKELVLMLNELFGKFDQIAKEHECMRIKIL
GDCYYCVSGLPLSLPDHAINCVRMGLDMCRAIRKLRAATGVDINMRVGVHSGSVLCGVIG


<font color=red>  [Part of this file has been deleted for brevity]</font>

&gt; Q83IL8
VEAIKRGTVIDHIPAQIGFKLLSLFKLTETDQRITIGLNLPSGEMGRKDLIKIENTFLSE
EQVDQLALYAPQATVNRIDNYEVVGKSRPSLP
&gt; Q7P144
VEALKQGTVIDHIPAGEGVKILRLFKLTETGERVTVGLNLVSRHMGSKDLIKVENVALTE
EQANELALFAPKATVNVIDNFEVVKKHKLTLP
&gt; Q7MZ14
VEAIRCGTVIDHIPAQVGFKLLSLFKLTETDQRITIGLNLPSNRLGKKDLIKIENTFLTE
QQANQLAMYAPNATVNCIENYEVVKKLPINLP
&gt; Q7MX57
VAAIRNGIVIDHIPPTKLFKVATLLQLDDLDKRITIGNNLRSRSHGSKGVIKIEDKTFEE
EELNRIALIAPNVRLNIIRDYEVVEKRQVEVP
&gt; Q7MHF0
VEAIKNGTVIDHIPAQVGIKVLKLFDMHNSSQRVTIGLNLPSSALGNKDLLKIENVFINE
EQASKLALYAPHATVNQIEDYQVVKKLALELP
&gt; Q58801
VKKITNGTVIDHIDAGKALMVFKVLNVPKETSVMIAINVPSKKKGKKDILKIEGIELKKE
DVDKISLISPDVTINIIRNGKVVEKLKPQIP
&gt; P96175
VEAICNGYVIDHIPSGQGVKILRLFSLTDTKQRVTVGFNLPSHDGTTKDLIKVENTEITK
SQANQLALLAPNATVNIIENFKVTDKHSLALP
&gt; P96111
GIKPIENGTVIDHIAKGKTPEEIYSTILKIRKILRLYDVDSADGIFRSSDGSFKGYISLP
DRYLSKKEIKKLSAISPNTTVNIIKNSTVVEKYRIKLP
&gt; P77919
VSAIKEGTVIDHIPAGKGLKVIEILKLGKLTNGGAVLLAMNVPSKKLGRKDIVKVEGRFL
SEEEVNKIALVAPNATVNIIRDYKVVEKFKVEVP
&gt; P74766
VSKIKNGTVIDHIPAGRAFAVLNVLGIKGHEGFRIALVINVDSKKMGKKDIVKIEDKEIS
DTEANLITLIAPTATINIVREYEVVKKTKLEVP
&gt; P57451
VEAIKSGSVIDHIPEYIGFKLLSLFRFTETEKRITIGLNLPSKKLGRKDIIKIENTFLSD
EQINQLAIYAPHATVNYINEYNLVRKVFPTLP
&gt; P19936
VEAIKCGTVIDHIPAQIGFKLLTLFKLTATDQRITIGLNLPSNELGRKDLIKIENTFLTE
QQANQLAMYAPKATVNRIDNYEVVRKLTLSLP
&gt; P08421
VEAIKCGTVIDHIPAQVGFKLLSLFKLTETDQRITIGLNLPSGEMGRKDLIKIENTFLTE
EQVNQLALYAPQATVNRIDNYDVVGKSRPSLP
&gt; P00478
VEAIKRGTVIDHIPAQIGFKLLSLFKLTETDQRITIGLNLPSGEMGRKDLIKIENTFLSE
DQVDQLALYAPQATVNRIDNYEVVGKSRPSLP
&gt; O58452
VSAIKEGTVIDHIPAGKGLKVIEILGLSKLSNGGSVLLAMNVPSKKLGRKDIVKVEGKFL
SEEEVNKIALVAPTATVNIIRNYKVVEKFKVEVP
&gt; O30129
VSKIKEGTVIDHINAGKALLVLKILKIQPGTDLTVSMAMNVPSSKMGKKDIVKVEGMFIR
DEELNKIALISPNATINLIRDYEIERKFKVSPP
&gt; O26938
VKPIKNGTVIDHITANRSLNVLNILGLPDGRSKVTVAMNMDSSQLGSKDIVKIENRELKP
SEVDQIALIAPRATINIVRDYKIVEKAKVRL
</pre>
</td></tr></table><p>







<!-- OUTPUT FILE FORMAT 
     Description and example(s) of output file formats.  Should provide enough
     information to write and parse the file.  Should describe the format in 
     unusual cases - null input, etc.  
     If the standard description of the avalable report formats is required, 
     use:   #include file="inc/reportformats.ihtml"
     Use "Outputs a graph to the specified graphics device."
     or  "outputs a report format file. The default format is ..."
     if appropriate.
-->
<a name="4.0"></a>
<br><br><br><H2> 4.0   OUTPUT FILE FORMAT         </H2>

<b>DHF file (domain hits file)</b>
<br>The format of the DHF file (domain hits file) of hit sequences generated by SIGSCAN (Figure 1)
is described fully in <a href="seqsearch.html">SEQSEARCH documentation</a> and only summarised here.
The file contains two lines per hit, the first is a description of the hit in 16 text tokens delimited by '^'. The second line contains the protein sequence.
The first 4 tokens refer to the hit (sequence) itself, the tokens are 
<UL>
<LI>(i) Accession number
<LI>(ii)  Database code, 
<LI>(iii - iv) Start and end positions of the hit relative to the full length sequence. 
</UL>

<br>The next 9 tokens refer to the domain family, superfamily etc for which the signature was derived and are as follows: 
<UL>
<LI>(v)  Type of domain (one of 'SCOP' or 'CATH'), 
<LI>(vi)  SCOP or CATH domain identifier.  
<LI>(vii) SCOP or CATH node unique identifier, e.g. SCOP Family Sunid.
<LI>(viii) Domain class.  Textual description of the 'Class' (SCOP and CATH domains). 
<LI>(ix) Domain architecture. Textual description of the 'Architecture' (CATH only). 
<LI>(x) Domain topology. Textual description of the 'Topology' (CATH only).  
<LI>(xi) Domain fold. Textual description of the 'Fold' (SCOP domains only).  
<LI>(xii) Domain superfamily. Textual description of the 'Superfamily' (SCOP and CATH domains).  
<LI>(xiii) Domain family. Textual description of the 'Fold' (SCOP only). 
</UL>

<br>The next 4 tokens refer to the hit, specifically, information about the search result as follows: 
<UL>
<LI>(xiv) Model type.  The type of model that was used to generate the hit. For DHF files generated by using SIGSCAN a value of SPARSE (sparse protein signature) is given.  Several other values are possible, however, see <a href="seqsearch.html">SEQSEARCH documentation</a>.
<LI>(xv) SC - Score of hit from search algoritm  (not written by SIGSCAN).
<LI>(xvi) P-value of hit (not written by SIGSCAN).
<LI>(xvii) E-value of hit (not written by SIGSCAN).
</UL>



<br><br>
<b>DAF file (domain alignment file)</b>
<br>
The format of the DAF file (domain alignment file, Figure 2) generated by SIGSCAN 
is described fully in <a href="domainalign.html">DOMAINALIGN documentation</a> and
is only summarised here. 

<br>
It conforms to EMBOSS "simple" multiple sequence alignment format and includes domain classification records (in comment lines beginning with '#') for the node for which the signature was generated. The classification records are TY (domain type, either SCOP or CATH), CL (class), FO (fold), SF (superfamily) and FA (family).  For CATH domains, AR (architecture) and TP (topology) may also be given.  A <b>unique identifier</b> for the node is given after <b>SI</b>. 
<br>There are multiple blocks that contain the accession numbers, positions and aligned sequences. An accession number is given for each hit.  The positions are the start and end residue positions of the appropriate section of sequence. The sequence uses '-' as a gap character.  A 'SIGNATURE' line is given as a markup line underneath the sequence (signature positions are marked with a '*').



<a name="output.1"></a>
<h3>Output files for usage example </h3>
<p><h3>File: SIGSCAN.dhf</h3>
<table width="90%"><tr><td bgcolor="#CCFFCC">
<pre>
&gt; P00478^.^10^91^SCOP^.^54894^Alpha and beta proteins (a+b)^.^.^Ferredoxin-like^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^SPARSE^4.67^0.000e+00^0.000e+00
VEAIKRGTVIDHIPAQIGFKLLSLFKLTETDQRITIGLNLPSGEMGRKDLIKIENTFLSEDQVDQLALYAPQATVNRIDNYEVVGKSRPSLP
&gt; Q83IL8^.^10^91^SCOP^.^54894^Alpha and beta proteins (a+b)^.^.^Ferredoxin-like^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^SPARSE^4.40^0.000e+00^0.000e+00
VEAIKRGTVIDHIPAQIGFKLLSLFKLTETDQRITIGLNLPSGEMGRKDLIKIENTFLSEEQVDQLALYAPQATVNRIDNYEVVGKSRPSLP
&gt; Q8Z130^.^10^91^SCOP^.^54894^Alpha and beta proteins (a+b)^.^.^Ferredoxin-like^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^SPARSE^4.07^0.000e+00^0.000e+00
VEAIKCGTVIDHIPAQVGFKLLSLFKLTETDQRITIGLNLPSGEMGRKDLIKIENTFLTDEQVNQLALYAPQATVNRIDNYDVVGKSRPSLP
&gt; P08421^.^10^91^SCOP^.^54894^Alpha and beta proteins (a+b)^.^.^Ferredoxin-like^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^SPARSE^4.07^0.000e+00^0.000e+00
VEAIKCGTVIDHIPAQVGFKLLSLFKLTETDQRITIGLNLPSGEMGRKDLIKIENTFLTEEQVNQLALYAPQATVNRIDNYDVVGKSRPSLP
&gt; Q8K9H8^.^10^91^SCOP^.^54894^Alpha and beta proteins (a+b)^.^.^Ferredoxin-like^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^SPARSE^3.67^0.000e+00^0.000e+00
VEAIKSGSVIDHIPAHIGFKLLSLFRFTETEKRITIGLNLPSQKLDKKDIIKIENTFLSDDQINQLAIYAPCATVNYIEKYNLVGKIFPSLP
&gt; Q9HKM3^.^11^92^SCOP^.^54894^Alpha and beta proteins (a+b)^.^.^Ferredoxin-like^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^SPARSE^3.20^0.000e+00^0.000e+00
ISKIRDGTVIDHVPSGKGIRVIGVLGVHEDVNYTVSLAIHVPSNKMGFKDVIKIENRFLDRNELDMISLIAPNATISIIKNYEISEKFQVELP
&gt; Q9HHN3^.^11^92^SCOP^.^54894^Alpha and beta proteins (a+b)^.^.^Ferredoxin-like^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^SPARSE^2.87^0.000e+00^0.000e+00
VSKIQAGTVIDHIPAGQALQVLQILGTNGASDDQITVGMNVTSERHHRKDIVKIEGRELSQDEVDVLSLIAPDATINIVRDYEVDEKRRVDRP
&gt; P57451^.^10^91^SCOP^.^54894^Alpha and beta proteins (a+b)^.^.^Ferredoxin-like^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^SPARSE^2.80^0.000e+00^0.000e+00
VEAIKSGSVIDHIPEYIGFKLLSLFRFTETEKRITIGLNLPSKKLGRKDIIKIENTFLSDEQINQLAIYAPHATVNYINEYNLVRKVFPTLP
&gt; Q8ZB38^.^10^91^SCOP^.^54894^Alpha and beta proteins (a+b)^.^.^Ferredoxin-like^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^SPARSE^2.73^0.000e+00^0.000e+00
VEAIKCGTVIDHIPAQIGFKLLSLFKLTATDQRITIGLNLPSKRSGRKDLIKIENTFLTEQQANQLAMYAPDATVNRIDNYEVVKKLTLSLP
&gt; P19936^.^10^91^SCOP^.^54894^Alpha and beta proteins (a+b)^.^.^Ferredoxin-like^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^SPARSE^2.73^0.000e+00^0.000e+00
VEAIKCGTVIDHIPAQIGFKLLTLFKLTATDQRITIGLNLPSNELGRKDLIKIENTFLTEQQANQLAMYAPKATVNRIDNYEVVRKLTLSLP
&gt; Q97B28^.^11^92^SCOP^.^54894^Alpha and beta proteins (a+b)^.^.^Ferredoxin-like^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^SPARSE^2.60^0.000e+00^0.000e+00
ISKIKDGTVIDHIPSGKALRVLSILGIRDDVDYTVSVGMHVPSSKMEYKDVIKIENRSLDKNELDMISLTAPNATISIIKNYEISEKFKVELP
&gt; Q87LF7^.^10^91^SCOP^.^54894^Alpha and beta proteins (a+b)^.^.^Ferredoxin-like^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^SPARSE^2.53^0.000e+00^0.000e+00
VEAIKNGTVIDHIPAQIGIKVLKLFDMHNSSQRVTIGLNLPSSALGHKDLLKIENVFINEEQASKLALYAPHATVNQIENYEVVKKLALELP
&gt; Q7MZ14^.^10^91^SCOP^.^54894^Alpha and beta proteins (a+b)^.^.^Ferredoxin-like^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^SPARSE^2.47^0.000e+00^0.000e+00
VEAIRCGTVIDHIPAQVGFKLLSLFKLTETDQRITIGLNLPSNRLGKKDLIKIENTFLTEQQANQLAMYAPNATVNCIENYEVVKKLPINLP
&gt; Q8ZTG2^.^11^92^SCOP^.^54894^Alpha and beta proteins (a+b)^.^.^Ferredoxin-like^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^SPARSE^2.33^0.000e+00^0.000e+00
VSKIENGTVIDHIPAGRALTVLRILGISGKEGLRVALVMNVESKKLGKKDIVKIEGRELTPEEVNIISAVAPTATINIIRNFAVVKKFKVTPP
&gt; Q9KP65^.^10^91^SCOP^.^54894^Alpha and beta proteins (a+b)^.^.^Ferredoxin-like^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^SPARSE^2.33^0.000e+00^0.000e+00
VEAIKNGTVIDHIPAKVGIKVLKLFDMHNSAQRVTIGLNLPSSALGSKDLLKIENVFISEAQANKLALYAPHATVNQIENYEVVKKLALQLP
&gt; O30129^.^11^92^SCOP^.^54894^Alpha and beta proteins (a+b)^.^.^Ferredoxin-like^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^SPARSE^2.27^0.000e+00^0.000e+00
VSKIKEGTVIDHINAGKALLVLKILKIQPGTDLTVSMAMNVPSSKMGKKDIVKVEGMFIRDEELNKIALISPNATINLIRDYEIERKFKVSPP
&gt; Q8D1W6^.^10^91^SCOP^.^54894^Alpha and beta proteins (a+b)^.^.^Ferredoxin-like^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^SPARSE^2.27^0.000e+00^0.000e+00
VEAIFGGTVIDHIPAQVGLKLLSLFKWLHTKERITMGLNLPSNQQKKKDLIKLENVLLNEDQANQLSIYAPLATVNQIKNYIVIKKQKLKLP
&gt; Q7MHF0^.^10^91^SCOP^.^54894^Alpha and beta proteins (a+b)^.^.^Ferredoxin-like^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^SPARSE^2.20^0.000e+00^0.000e+00
VEAIKNGTVIDHIPAQVGIKVLKLFDMHNSSQRVTIGLNLPSSALGNKDLLKIENVFINEEQASKLALYAPHATVNQIEDYQVVKKLALELP
&gt; Q8DCF7^.^10^91^SCOP^.^54894^Alpha and beta proteins (a+b)^.^.^Ferredoxin-like^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^SPARSE^2.20^0.000e+00^0.000e+00
VEAIKNGTVIDHIPAQVGIKVLKLFDMHNSSQRVTIGLNLPSSALGNKDLLKIENVFINEEQASKLALYAPHATVNQIEDYQVVKKLALELP
&gt; Q9UX07^.^11^92^SCOP^.^54894^Alpha and beta proteins (a+b)^.^.^Ferredoxin-like^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^SPARSE^2.07^0.000e+00^0.000e+00
VSKIRNGTVIDHIPAGRALAVLRILGIRGSEGYRVALVMNVESKKIGRKDIVKIEDRVIDEKEASLITLIAPSATINIIRDYVVTEKRHLEVP
&gt; Q9K1K9^.^10^91^SCOP^.^54894^Alpha and beta proteins (a+b)^.^.^Ferredoxin-like^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^SPARSE^1.93^0.000e+00^0.000e+00
VEAIEKGTVIDHIPAGRGLTILRQFKLLHYGNAVTVGFNLPSKTQGSKDIIKIKGVCLDDKAADRLALFAPEAVVNTIDNFKVVQKRHLNLP
&gt; O58452^.^12^93^SCOP^.^54894^Alpha and beta proteins (a+b)^.^.^Ferredoxin-like^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^SPARSE^1.93^0.000e+00^0.000e+00
VSAIKEGTVIDHIPAGKGLKVIEILGLSKLSNGGSVLLAMNVPSKKLGRKDIVKVEGKFLSEEEVNKIALVAPTATVNIIRNYKVVEKFKVEVP
&gt; P74766^.^11^92^SCOP^.^54894^Alpha and beta proteins (a+b)^.^.^Ferredoxin-like^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^SPARSE^1.93^0.000e+00^0.000e+00
VSKIKNGTVIDHIPAGRAFAVLNVLGIKGHEGFRIALVINVDSKKMGKKDIVKIEDKEISDTEANLITLIAPTATINIVREYEVVKKTKLEVP
&gt; Q7P144^.^10^91^SCOP^.^54894^Alpha and beta proteins (a+b)^.^.^Ferredoxin-like^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^SPARSE^1.80^0.000e+00^0.000e+00
VEALKQGTVIDHIPAGEGVKILRLFKLTETGERVTVGLNLVSRHMGSKDLIKVENVALTEEQANELALFAPKATVNVIDNFEVVKKHKLTLP
&gt; Q9JWY6^.^10^91^SCOP^.^54894^Alpha and beta proteins (a+b)^.^.^Ferredoxin-like^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^SPARSE^1.60^0.000e+00^0.000e+00
VEAIEKGTVIDHIPAGRGLTILRQFKLLHYGNAVTVGFNLPSKTQGSKDIIKIKGVCLDDKAADRLALFAPEAVVNTIDHFKVVQKRHLNLP


<font color=red>  [Part of this file has been deleted for brevity]</font>

VQAEAFDSVTIYFSDIVGFTALSAESTPMQVVTLLNDLYTCFDAVIDNFDVYKVETIGDAYMVVSGLPVRNGRLHACEVARMALALLDAVRSFRIRHRPQEQLRLRIGIHTGPVCAGVVGLKMPRYCLFGDTVNTASRMESNGEALKIHLSSETKAVLEEFGGFELEL
&gt; Q891I9^.^9^90^SCOP^.^54894^Alpha and beta proteins (a+b)^.^.^Ferredoxin-like^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^SPARSE^0.07^0.000e+00^0.000e+00
ITSIKDGIVIDHIKSGYGIKIFNYLNLKNVEYSVALIMNVFSSKLGKKDIIKIANKEIDIDFTVLGLIDPTITINIIEDEKIKEKLNLELP
&gt; P18293^.^38^119^SCOP^.^54894^Alpha and beta proteins (a+b)^.^.^Ferredoxin-like^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^SPARSE^0.07^0.000e+00^0.000e+00
VQAEAFDSVTIYFSDIVGFTALSAESTPMQVVTLLNDLYTCFDAVIDNFDVYKVETIGDAYMVVSGLPVRNGQLHAREVARMALALLDAVRSFRIRHRPQEQLRLRIGIHTGPVCAGVVGLKMPRYCLFGDTVNTASRMESNGEALRIHLSSETKAVLEEFDGFELEL
&gt; O02740^.^32^113^SCOP^.^54894^Alpha and beta proteins (a+b)^.^.^Ferredoxin-like^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^SPARSE^0.07^0.000e+00^0.000e+00
DLVTLYFSDIVGFTTISAMSEPIEVVDLLNDLYTLFDAIIGSHDVYKVETIGDAYMVASGLPKRNGMRHAAEIANMSLDILSSVGTFKMRHMPEVPVRIRIGLHSGPVVAGVVGLTMPRYCLFGDTVNTASRMESTGLPYRIHVSHSTVTILRTLGEGYEVE
&gt; P51841^.^32^113^SCOP^.^54894^Alpha and beta proteins (a+b)^.^.^Ferredoxin-like^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^SPARSE^0.07^0.000e+00^0.000e+00
DLVTLYFSDIVGFTTISAMSEPIEVVDLLNDLYTLFDAIIGSHDVYKVETIGDAYMVASGLPKRNGSRHAAEIANMSLDILSSVGTFKMRHMPEVPVRIRIGLHSGPVVAGVVGLTMPRYCLFGDTVNTASRMESTGLPYRIHVSLSTVTILQNLSEGYEVE
&gt; Q8NFM4^.^49^130^SCOP^.^54894^Alpha and beta proteins (a+b)^.^.^Ferredoxin-like^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^SPARSE^0.07^0.000e+00^0.000e+00
VCVLFASVPDFKEFYSESNINHEGLECLRLLNEIIADFDELLSKPKFSGVEKIKTIGSTYMAATGLNATSGQDAQQDAERSCSHLGTMVEFAVALGSKLDVINKHSFNNFRLRVGLNHGPVVAGVIGAQKPQYDIWGNTVNVASRMESTGVLGKIQVTEET
&gt; P46197^.^38^119^SCOP^.^54894^Alpha and beta proteins (a+b)^.^.^Ferredoxin-like^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^SPARSE^0.07^0.000e+00^0.000e+00
VQAEAFDSVTIYFSDIVGFTALSAESTPMQVVTLLNDLYTCFDAIIDNFDVYKVETIGDAYMVVSGLPGRNGQRHAPEIARMALALLDAVSSFRIRHRPHDQLRLRIGVHTGPVCAGVVGLKMPRYCLFGDTVNTASRMESNGQALKIHVSSTTKDALDELGCFQLEL
&gt; P19686^.^65^146^SCOP^.^54894^Alpha and beta proteins (a+b)^.^.^Ferredoxin-like^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^SPARSE^0.00^0.000e+00^0.000e+00
VQAKKFNEVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHRESDTHAVQIALMALKMMELSNEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPG
&gt; P19687^.^66^147^SCOP^.^54894^Alpha and beta proteins (a+b)^.^.^Ferredoxin-like^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^SPARSE^0.00^0.000e+00^0.000e+00
AVQAKRFGNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDRQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSHEVVSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPG
&gt; O60503^.^60^141^SCOP^.^54894^Alpha and beta proteins (a+b)^.^.^Ferredoxin-like^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^SPARSE^0.00^0.000e+00^0.000e+00
VSILFADIVGFTKMSANKSAHALVGLLNDLFGRFDRLCEETKCEKISTLGDCYYCVAGCPEPRADHAYCCIEMGLGMIKAIEQFCQEKKEMVNMRVGVHTGTVLCGILGMRRFKFDVWSNDVNLANLMEQLGVAGKVHISEATAKYLDDRYEMEDGKVIERLGQSVVADQLKGLKTYLI
&gt; P97490^.^75^156^SCOP^.^54894^Alpha and beta proteins (a+b)^.^.^Ferredoxin-like^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^SPARSE^0.00^0.000e+00^0.000e+00
DAVGVMFASIPGFADFYSQTEMNNQGVECLRLLNEIIADFDELLGEDRFQDIEKIKTIGSTYMAVSGLSPEKQQCEDKWGHLCALADFSLALTESIQEINKHSFNNFELRIGISHGSVVAGVIGAKKPQYDIWGKTVNLASRMDSTGVSGRIQVPEETYLIL
&gt; P51830^.^60^141^SCOP^.^54894^Alpha and beta proteins (a+b)^.^.^Ferredoxin-like^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^SPARSE^0.00^0.000e+00^0.000e+00
VSILFADIVGFTKMSANKSAHALVGLLNDLFGRFDRLCEQTKCEKISTLGDCYYCVAGCPEPRADHAYCCIEMGLGMIKAIEQFCQEKKEMVNMRVGVHTGTVLCGILGMRRFKFDVWSNDVNLANLMEQLGVAGKVHISEATAKYLDDRYEMEDGRVIERLGQSVVADQLKGLKTYLI
&gt; Q02108^.^65^146^SCOP^.^54894^Alpha and beta proteins (a+b)^.^.^Ferredoxin-like^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^SPARSE^0.00^0.000e+00^0.000e+00
VQAKKFSNVTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHKESDTHAVQIALMALKMMELSDEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPG
&gt; Q9DGG6^.^62^143^SCOP^.^54894^Alpha and beta proteins (a+b)^.^.^Ferredoxin-like^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^SPARSE^0.00^0.000e+00^0.000e+00
EQVSILFADIVGFTKMSANKSAHALVGLLNDLFGRFDRLCEDTKCEKISTLGDCYYCVAGCPEPRADHAYCCIEMGLGMIKAIEQFCQEKKEMVNMRVGVHTGTVLCGILGMRRFKFDVWSNDVNLANLMEQLGVAGKVHISEATAKYLDDRYEMEDGKVTERVGQSAVADQLKGLKTYLI
&gt; Q9ERL9^.^57^138^SCOP^.^54894^Alpha and beta proteins (a+b)^.^.^Ferredoxin-like^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^SPARSE^0.00^0.000e+00^0.000e+00
VTMLFSDIVGFTAICSQCSPLQVITMLNALYTRFDQQCGELDVYKVETIGDAYCVAGGLHRESDTHAVQIALMALKMMELSNEVMSPHGEPIKMRIGLHSGSVFAGVVGVKMPRYCLFGNNVTLANKFESCSVPRKINVSPTTYRLLKDCPG
&gt; P30803^.^0^81^SCOP^.^54894^Alpha and beta proteins (a+b)^.^.^Ferredoxin-like^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^SPARSE^0.00^0.000e+00^0.000e+00
VAVMFASIANFSEFYVELEANNEGVECLRVLNEIIADFDEIISEDRFRQLEKIKTIGSTYMAASGLNDSTYDKVGKTHIKALADFAMKLMDQMKYINEHSFNNFQMKIGLNIGPVVAGVIGARKPQYDIWGNTVNVASRMDSTGVPDRIQVTTDMYQVL
&gt; P40145^.^75^156^SCOP^.^54894^Alpha and beta proteins (a+b)^.^.^Ferredoxin-like^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^SPARSE^0.00^0.000e+00^0.000e+00
DAVGVMFASIPGFADFYSQTEMNNQGVECLRLLNEIIADFDELLGEDRFQDIEKIKTIGSTYMAVSGLSPEKQQCEDKWGHLCALADFSLALTESIQEINKHSFNNFELRIGISHGSVVAGVIGAKKPQYDIWGKTVNLASRMDSTGVSGRIQVPEETYLIL
&gt; O19179^.^30^111^SCOP^.^54894^Alpha and beta proteins (a+b)^.^.^Ferredoxin-like^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^SPARSE^0.00^0.000e+00^0.000e+00
VTLYFSDIVGFTTISAMSEPIEVVDLLNDLYTLFDAIIGSHDVYKVETIGDAYMVASGLPQRNGQRHAAEIANMALDILSAVGSFRMRHMPEVPVRIRIGLHSGPCVAGVVGLTMPRYCLFGDTVNTASRMESTGLPYRIHVNMSTVRILHALDEGFQTEV
&gt; P51840^.^30^111^SCOP^.^54894^Alpha and beta proteins (a+b)^.^.^Ferredoxin-like^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^SPARSE^0.00^0.000e+00^0.000e+00
VTLYFSDIVGFTTISAMSEPIEVVDLLNDLYTLFDAIIGSHDVYKVETIGDAYMVASGLPQRNGQRHAAEIANMSLDILSAVGSFRMRHMPEVPVRIRIGLHSGPCVAGVVGLTMPRYCLFGDTVNTASRMESTGLPYRIHVNMSTVRIL
&gt; P40146^.^75^156^SCOP^.^54894^Alpha and beta proteins (a+b)^.^.^Ferredoxin-like^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^SPARSE^0.00^0.000e+00^0.000e+00
DAVGVMFASIPGFADFYSQTEMNNQGVECLRLLNEIIADFDELLGEDRFQDIEKIKTIGSTYMAVSGLSPEKQQCEDKWGHLCALADFSLALTESIQEINKHSFNNFELRIGISHGSVVAGVIGAKKPQYDIWGKTVNLASRMDSTGVSGRIQVPEETYLIL
&gt; P52785^.^30^111^SCOP^.^54894^Alpha and beta proteins (a+b)^.^.^Ferredoxin-like^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^SPARSE^0.00^0.000e+00^0.000e+00
VTLYFSDIVGFTTISAMSEPIEVVDLLNDLYTLFDAIIGAHDVYKVETIGDAYMVASGLPQRNGQRHAAEIANMSLDILSAVGSFRMRHMPEVPVRIRIGLHSGPCVAGVVGLTMPRYCLFGDTVNTASRMESTGLPYRIHVNMSTVRILRSLDQGFQME
&gt; P98999^.^62^143^SCOP^.^54894^Alpha and beta proteins (a+b)^.^.^Ferredoxin-like^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^SPARSE^0.00^0.000e+00^0.000e+00
EQVSILFADIVGFTKMSANKSAHALVGLLNDLFGRFDRLCEETKCEKISTLGDCYYCVAGCPEPRPDHAYCCIEMGLGMIEAIDQFCQEKKEMVNMRVGVHTGTVLCGILGMRRFKFDVWSNDVNLANLMEQLGVAGKVHISEKTARYLD
&gt; P30804^.^0^81^SCOP^.^54894^Alpha and beta proteins (a+b)^.^.^Ferredoxin-like^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^SPARSE^-0.07^0.000e+00^0.000e+00
VAVMFASIANFSEFYVELEANNEGVECLRLLNEIIADFDEIISEERFRQLEKIKTIGSTYMAASGLNASTYDQAGRSHITALADYAMRLMEQMKHINEHSFNNFQMKIGLNMGPVVAGVIGARKPQYDIWGNTVNVSSRMDSTGVPDRIQVTTDLYQVL
&gt; Q01341^.^0^81^SCOP^.^54894^Alpha and beta proteins (a+b)^.^.^Ferredoxin-like^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^SPARSE^-0.07^0.000e+00^0.000e+00
VAVMFASIANFSEFYVELEANNEGVECLRLLNEIIADFDEIISEERFRQLEKIKTIGSTYMAASGLNASTYDQVGRSHITALADYAMRLMEQMKHINEHSFNNFQMKIGLNMGPVVAGVIGARKPQYDIWGNTVNVSSRMDSTGVPDRIQVTTDLYQVL
&gt; Q03343^.^0^81^SCOP^.^54894^Alpha and beta proteins (a+b)^.^.^Ferredoxin-like^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^SPARSE^-0.07^0.000e+00^0.000e+00
VAVMFASIANFSEFYVELEANNEGVECLRLLNEIIADFDEIISEERFRQLEKIKTIGSTYMAASGLNASTYDQVGRSHITALADYAMRLMEQMKHINEHSFNNFQMKIGLNMGPVVAGVIGARKPQYDIWGNTVNVSSRMDSTGVPDRIQVTTDLYQVL
&gt; O95622^.^0^81^SCOP^.^54894^Alpha and beta proteins (a+b)^.^.^Ferredoxin-like^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain^SPARSE^-0.07^0.000e+00^0.000e+00
VAVMFASIANFSEFYVELEANNEGVECLRLLNEIIADFDEIISEDRFRQLEKIKTIGSTYMAASGLNDSTYDKVGKTHIKALADFAMKLMDQMKYINEHSFNNFQMKIGLNIGPVVAGVIGARKPQYDIWGNTVNVASRMDSTGVPDRIQVTTDMYQVL
</pre>
</td></tr></table><p>
<p><h3>File: SIGSCAN.aln</h3>
<table width="90%"><tr><td bgcolor="#CCFFCC">
<pre>
# DE   Results of signature search
# XX
# TY   SCOP
# XX
# CL   Alpha and beta proteins (a+b)
# XX
# FO   Ferredoxin-like
# XX
# SF   Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain
# XX
# FA   Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain
# XX
# SI   54894
# XX
P00478    1      VEAIKRGTVIDHIPAQIGFKLLSLFKLTETDQRITIGLNLPSGEMGRKDLIKI 53
SIGNATURE -      ----------*-*--------------------------*-------------
P00478    54     ENTFLSEDQVDQLALYAPQATVNRIDNYEVVGKSRPSLP               106
SIGNATURE -      ---*---*--*----*-*----*--***---*---*--*              
P00478    107    .                                                     159
SIGNATURE -      .                                                    
P00478    160    .                                                     212
SIGNATURE -      .                                                    
P00478    213    .                                                     265
SIGNATURE -      .                                                    
# XX
Q83IL8    1      VEAIKRGTVIDHIPAQIGFKLLSLFKLTETDQRITIGLNLPSGEMGRKDLIKI 53
SIGNATURE -      ----------*-*--------------------------*-------------
Q83IL8    54     ENTFLSEEQVDQLALYAPQATVNRIDNYEVVGKSRPSLP               106
SIGNATURE -      ---*---*--*----*-*----*--***---*---*--*              
Q83IL8    107    .                                                     159
SIGNATURE -      .                                                    
Q83IL8    160    .                                                     212
SIGNATURE -      .                                                    
Q83IL8    213    .                                                     265
SIGNATURE -      .                                                    
# XX
Q8Z130    1      VEAIKCGTVIDHIPAQVGFKLLSLFKLTETDQRITIGLNLPSGEMGRKDLIKI 53
SIGNATURE -      ----------*-*--------------------------*-------------
Q8Z130    54     ENTFLTDEQVNQLALYAPQATVNRIDNYDVVGKSRPSLP               106
SIGNATURE -      ---*---*--*----*-*----*--***---*---*--*              
Q8Z130    107    .                                                     159
SIGNATURE -      .                                                    
Q8Z130    160    .                                                     212
SIGNATURE -      .                                                    
Q8Z130    213    .                                                     265
SIGNATURE -      .                                                    
# XX
P08421    1      VEAIKCGTVIDHIPAQVGFKLLSLFKLTETDQRITIGLNLPSGEMGRKDLIKI 53
SIGNATURE -      ----------*-*--------------------------*-------------
P08421    54     ENTFLTEEQVNQLALYAPQATVNRIDNYDVVGKSRPSLP               106


<font color=red>  [Part of this file has been deleted for brevity]</font>

SIGNATURE -      ---------*-*--------------------------*--------------
P98999    107    CGILGMRRFKFDVWSNDVNLANLMEQLGVAGKVHISEKTARYLD          159
SIGNATURE -      --*---*--*----*-*----*--***---*---*--*------         
P98999    160    .                                                     212
SIGNATURE -      .                                                    
P98999    213    .                                                     265
SIGNATURE -      .                                                    
# XX
P30804    1      VAVMFASIANFSEFYVELEANNEGVECLRLLNEIIADFDEIISEERFRQLEKI 53
SIGNATURE -      *-*--------------------------*----------------*---*--
P30804    54     KTIGSTYMAASGLNASTYDQAGRSHITALADYAMRLMEQMKHINEHSFNNFQM 106
SIGNATURE -      *----*-*----*--***---*---*--*------------------------
P30804    107    KIGLNMGPVVAGVIGARKPQYDIWGNTVNVSSRMDSTGVPDRIQVTTDLYQVL 159
SIGNATURE -      -----------------------------------------------------
P30804    160    .                                                     212
SIGNATURE -      .                                                    
P30804    213    .                                                     265
SIGNATURE -      .                                                    
# XX
Q01341    1      VAVMFASIANFSEFYVELEANNEGVECLRLLNEIIADFDEIISEERFRQLEKI 53
SIGNATURE -      *-*--------------------------*----------------*---*--
Q01341    54     KTIGSTYMAASGLNASTYDQVGRSHITALADYAMRLMEQMKHINEHSFNNFQM 106
SIGNATURE -      *----*-*----*--***---*---*--*------------------------
Q01341    107    KIGLNMGPVVAGVIGARKPQYDIWGNTVNVSSRMDSTGVPDRIQVTTDLYQVL 159
SIGNATURE -      -----------------------------------------------------
Q01341    160    .                                                     212
SIGNATURE -      .                                                    
Q01341    213    .                                                     265
SIGNATURE -      .                                                    
# XX
Q03343    1      VAVMFASIANFSEFYVELEANNEGVECLRLLNEIIADFDEIISEERFRQLEKI 53
SIGNATURE -      *-*--------------------------*----------------*---*--
Q03343    54     KTIGSTYMAASGLNASTYDQVGRSHITALADYAMRLMEQMKHINEHSFNNFQM 106
SIGNATURE -      *----*-*----*--***---*---*--*------------------------
Q03343    107    KIGLNMGPVVAGVIGARKPQYDIWGNTVNVSSRMDSTGVPDRIQVTTDLYQVL 159
SIGNATURE -      -----------------------------------------------------
Q03343    160    .                                                     212
SIGNATURE -      .                                                    
Q03343    213    .                                                     265
SIGNATURE -      .                                                    
# XX
O95622    1      VAVMFASIANFSEFYVELEANNEGVECLRLLNEIIADFDEIISEDRFRQLEKI 53
SIGNATURE -      *-*--------------------------*----------------*---*--
O95622    54     KTIGSTYMAASGLNDSTYDKVGKTHIKALADFAMKLMDQMKYINEHSFNNFQM 106
SIGNATURE -      *----*-*----*--***---*---*--*------------------------
O95622    107    KIGLNIGPVVAGVIGARKPQYDIWGNTVNVASRMDSTGVPDRIQVTTDMYQVL 159
SIGNATURE -      -----------------------------------------------------
O95622    160    .                                                     212
SIGNATURE -      .                                                    
O95622    213    .                                                     265
SIGNATURE -      .                                                    
</pre>
</td></tr></table><p>




<!-- DATA FILES         
     Any data files used (e.g. translation table file, substitution matrix 
     etc.  This includes example data file formats if they are not obvious.
     For a standard description of what data files are and how embossdata can
     be used to inspect and retrieve them, use:
     #include file="inc/localfiles.ihtml" 
-->

<a name="5.0"></a>
<br><br><br><H2> 5.0   DATA FILES                </H2>
SIGSCAN requires a residue substitution matrix.

<!-- USAGE
     Example usage, as run from the command-line.
     Many examples illustrating different behaviours is good.
-->
<a name="6.0"></a>
<br><br><br><H2> 6.0   USAGE                     </H2>

<table CELLSPACING=0 CELLPADDING=3 BGCOLOR="#f5f5ff" >
<tr><td>
<pre>
   Standard (Mandatory) qualifiers:
  [-siginfile]         infile     This option specifies the name of the
                                  signature file (input). A 'signature file'
                                  contains a sparse sequence signature
                                  suitable for use with the SIGSCAN and
                                  SIGSCANLIG programs. The files are generated
                                  by using SIGGEN and SIGGENLIG.
  [-dbsequence]        seqall     This option specifies the name of the
                                  database to search.
   -sub                matrixf    This option specifies the residue
                                  substitution matrix.
   -gapo               float      This option specifies the gap insertion
                                  penalty. The gap insertion penalty is the
                                  score taken away when a gap is created. The
                                  best value depends on the choice of
                                  comparison matrix. The default value assumes
                                  you are using the EBLOSUM62 matrix for
                                  protein sequences, and the EDNAMAT matrix
                                  for nucleotide sequences.
   -gape               float      This option specifies the gap extension
                                  penalty. The gap extension penalty is added
                                  to the standard gap penalty for each base or
                                  residue in the gap. This is how long gaps
                                  are penalized. Usually you will expect a few
                                  long gaps rather than many short gaps, so
                                  the gap extension penalty should be lower
                                  than the gap penalty.
   -nterm              menu       This option specifies the N-terminal
                                  matching option. This determines how the
                                  first signature position is aligned to a
                                  sequence from the database.
   -nhits              integer    This option specifies the maximum number of
                                  hits to output.
  [-hitsfile]          outfile    This option specifies the name of the DHF
                                  file (domain hits file) (output). A 'domain
                                  hits file' contains database hits
                                  (sequences) with domain classification
                                  information, in the DHF format (FASTA-like).
                                  The hits are relatives to a SCOP or CATH
                                  family (or other node in the structural
                                  hierarchies) and are found from a search of
                                  a sequence database, in this case, by using
                                  SIGSCAN. Files containing hits retrieved by
                                  PSIBLAST are generated by using SEQSEARCH or
                                  various types of HMM and profile by using
                                  LIBSCAN.
  [-alignfile]         outfile    Name of SAF file (signature alignment file)
                                  for signature-sequence alignments (output)
                                  help: "This option specifies the name of the
                                  SAF (signature alignment file) (output).A
                                  'signature alignment file' contains one or
                                  more signnature-sequence alignments. The
                                  file is in DAF format (CLUSTAL-like) and is
                                  annotated with bibliographic information,
                                  either the domain family classification (for
                                  SIGSCAN output) or ligand classification
                                  (for SIGSCANLIG output). The files generated
                                  by SIGSCAN will contain a
                                  signature-sequence alignment for a single
                                  signature against a library of one or more
                                  sequences. The files generated by using
                                  SIGSCANLIG will contain a signature-sequence
                                  alignment for a single query sequence
                                  against a library of one or more signatures.

   Additional (Optional) qualifiers: (none)
   Advanced (Unprompted) qualifiers: (none)
   Associated qualifiers:

   "-dbsequence" associated qualifiers
   -sbegin2            integer    Start of each sequence to be used
   -send2              integer    End of each sequence to be used
   -sreverse2          boolean    Reverse (if DNA)
   -sask2              boolean    Ask for begin/end/reverse
   -snucleotide2       boolean    Sequence is nucleotide
   -sprotein2          boolean    Sequence is protein
   -slower2            boolean    Make lower case
   -supper2            boolean    Make upper case
   -sformat2           string     Input sequence format
   -sdbname2           string     Database name
   -sid2               string     Entryname
   -ufo2               string     UFO features
   -fformat2           string     Features format
   -fopenfile2         string     Features file name

   "-hitsfile" associated qualifiers
   -odirectory3        string     Output directory

   "-alignfile" associated qualifiers
   -odirectory4        string     Output directory

   General qualifiers:
   -auto               boolean    Turn off prompts
   -stdout             boolean    Write standard output
   -filter             boolean    Read standard input, write standard output
   -options            boolean    Prompt for standard and additional values
   -debug              boolean    Write debug output to program.dbg
   -verbose            boolean    Report some/full command line options
   -help               boolean    Report command line options. More
                                  information on associated and general
                                  qualifiers can be found with -help -verbose
   -warning            boolean    Report warnings
   -error              boolean    Report errors
   -fatal              boolean    Report fatal errors
   -die                boolean    Report deaths

</pre>
</pre>
</td></tr>
</table>


<H3> 6.1   COMMAND LINE ARGUMENTS </H3>
 
<table border cellspacing=0 cellpadding=3 bgcolor="#ccccff">
<tr bgcolor="#FFFFCC">
<th align="left" colspan=2>Standard (Mandatory) qualifiers</th>
<th align="left">Allowed values</th>
<th align="left">Default</th>
</tr>

<tr>
<td>[-siginfile]<br>(Parameter 1)</td>
<td>This option specifies the name of the signature file (input). A 'signature file' contains a sparse sequence signature suitable for use with the SIGSCAN and SIGSCANLIG programs. The files are generated by using SIGGEN and SIGGENLIG.</td>
<td>Input file</td>
<td><b>Required</b></td>
</tr>

<tr>
<td>[-dbsequence]<br>(Parameter 2)</td>
<td>This option specifies the name of the database to search.</td>
<td>Readable sequence(s)</td>
<td><b>Required</b></td>
</tr>

<tr>
<td>-sub</td>
<td>This option specifies the residue substitution matrix.</td>
<td>Comparison matrix file in EMBOSS data path</td>
<td>EBLOSUM62</td>
</tr>

<tr>
<td>-gapo</td>
<td>This option specifies the gap insertion penalty. The gap insertion penalty is the score taken away when a gap is created. The best value depends on the choice of comparison matrix. The default value assumes you are using the EBLOSUM62 matrix for protein sequences, and the EDNAMAT matrix for nucleotide sequences.</td>
<td>Floating point number from 1.0 to 100.0</td>
<td>10.0 for any sequence</td>
</tr>

<tr>
<td>-gape</td>
<td>This option specifies the gap extension penalty. The gap extension penalty is added to the standard gap penalty for each base or residue in the gap. This is how long gaps are penalized. Usually you will expect a few long gaps rather than many short gaps, so the gap extension penalty should be lower than the gap penalty.</td>
<td>Floating point number from 0.0 to 10.0</td>
<td>0.5 for any sequence</td>
</tr>

<tr>
<td>-nterm</td>
<td>This option specifies the N-terminal matching option. This determines how the first signature position is aligned to a sequence from the database.</td>
<td><table><tr><td>1</td> <td><i>(Align anywhere and allow only complete signature-sequence fit)</i></td></tr><tr><td>2</td> <td><i>(Align anywhere and allow partial signature-sequence fit)</i></td></tr><tr><td>3</td> <td><i>(Use empirical gaps only)</i></td></tr></table></td>
<td>1</td>
</tr>

<tr>
<td>-nhits</td>
<td>This option specifies the maximum number of hits to output.</td>
<td>Any integer value</td>
<td>100</td>
</tr>

<tr>
<td>[-hitsfile]<br>(Parameter 3)</td>
<td>This option specifies the name of the DHF file (domain hits file) (output). A 'domain hits file' contains database hits (sequences) with domain classification information, in the DHF format (FASTA-like). The hits are relatives to a SCOP or CATH family (or other node in the structural hierarchies) and are found from a search of a sequence database, in this case, by using SIGSCAN. Files containing hits retrieved by PSIBLAST are generated by using SEQSEARCH or various types of HMM and profile by using LIBSCAN.</td>
<td>Output file</td>
<td>SIGSCAN.dhf</td>
</tr>

<tr>
<td>[-alignfile]<br>(Parameter 4)</td>
<td>Name of SAF file (signature alignment file) for signature-sequence alignments (output) help: "This option specifies the name of the SAF (signature alignment file) (output).A 'signature alignment file' contains one or more signnature-sequence alignments. The file is in DAF format (CLUSTAL-like) and is annotated with bibliographic information, either the domain family classification (for SIGSCAN output) or ligand classification (for SIGSCANLIG output). The files generated by SIGSCAN will contain a signature-sequence alignment for a single signature against a library of one or more sequences. The files generated by using SIGSCANLIG will contain a signature-sequence alignment for a single query sequence against a library of one or more signatures.</td>
<td>Output file</td>
<td>SIGSCAN.aln</td>
</tr>

<tr bgcolor="#FFFFCC">
<th align="left" colspan=2>Additional (Optional) qualifiers</th>
<th align="left">Allowed values</th>
<th align="left">Default</th>
</tr>

<tr>
<td colspan=4>(none)</td>
</tr>

<tr bgcolor="#FFFFCC">
<th align="left" colspan=2>Advanced (Unprompted) qualifiers</th>
<th align="left">Allowed values</th>
<th align="left">Default</th>
</tr>

<tr>
<td colspan=4>(none)</td>
</tr>

</table>


<H3> 6.2 EXAMPLE SESSION </H3>
An example of interactive use of sigscan is shown below.

<b>Here is a sample session with sigscan</b>
<p>

<p>
<table width="90%"><tr><td bgcolor="#CCFFFF"><pre>

% <b>sigscan </b>
Generate hits (DHF file) from a signature search.
Name of signature file (input): <b>../siggen-keep/54894.sig</b>
Name of database to search.: <b>swsmall</b>
Residue substitution matrix [EBLOSUM62]: <b></b>
Gap insertion penalty [10]: <b></b>
Gap extension penalty [0.5]: <b></b>
N-terminal matching options
         1 : Align anywhere and allow only complete signature-sequence fit
         2 : Align anywhere and allow partial signature-sequence fit
         3 : Use empirical gaps only
Select number [1]: <b></b>
Max. number of hits to output [100]: <b></b>
Name of DHF file (domain hits file) (output) [SIGSCAN.dhf]: <b></b>
Name of SAF file (signature alignment file) for signature-sequence alignments (output) help: <b></b>
"This option specifies the name of the SAF (signature alignment file) (output).A 'signature alignment file' contains one or more signnature-sequence alignments. The file is in DAF format (CLUSTAL-like) and is annotated with bibliographic information, either the domain family classification (for SIGSCAN output) or ligand classification (for SIGSCANLIG output). The files generated by SIGSCAN will contain a signature-sequence alignment for a single signature against a library of one or more sequences. The files generated by using SIGSCANLIG will contain a signature-sequence alignment for a single query sequence against a library of one or more signatures. [SIGSCAN.aln]: <b>
</b>

Signature file read ok
Signature compiled ok
Signature aligned to db ok
Hits file written ok
Alignments file written ok

</pre></td></tr></table><p>
<p>
<a href="#input.1">Go to the input files for this example</a><br><a href="#output.1">Go to the output files for this example</a><p><p>


<!-- <br><br>
The signature file /test_data/54894.sig was scanned against the swissprot database /test_data/swsmall to generate a DHF file (database hits) called /test_data/54894.dhf and a DAF file (signature-sequence alignments) called /test_data/54894.daf.  The output files contained no more than 100 hits in total.  When aligning and scoring the signature to a protein sequence, the residue substitution matrix EBLOSUM62, a gap insertion penalty of 10 and a gap extension penalty of 0.5 was used.  The first signature position was permitted to be aligned anywhere in the sequence without attracing a gap penalty and only complete signature-sequence fits were allowed, i.e. every signature position had to be aligned or otherwise the sequence was rejected (sequences smaller than the sum of the gap distances in the signature were rejected).
<br><br>


<!-- KNOWN BUGS & WARNINGS
     Bugs that have not yet been fixed, easily missued features, problems
     and caveats etc. Potentially stupid things the program will let you do.
-->
<a name="7.0"></a>
<br><br><br><H2> 7.0   KNOWN BUGS & WARNINGS     </H2>
None.








<!-- NOTES
     Important general remarks, including:
       Restrictions.
       Interesting behaviour.
       Useful things you can do with this program.
       Future plans.
       etc.
-->
<a name="8.0"></a>
<br><br><br><H2> 8.0   NOTES                     </H2>
SIGSCAN does not generate p-values or E-values.  DHF files of hits for which p-values or E-values are calculated may be generated by using <a href="libscan.html">LIBSCAN </a>. LIBSCAN provides searches for sparse protein signatures as well as various types of hidden Markov models and other profiles. 

<br><br>In the case a signature file is generated by hand, it is essential that the 
gap data given is listed in order of increasing gap size (see <a href="siggen.html">SIGGEN documentation </a>).


<H3> 8.1   GLOSSARY OF FILE TYPES    </H3>
<table BORDER CELLSPACING=5 CELLPADDING=5 BGCOLOR="#f5f5ff" >
<tr>
<td><b>FILE TYPE</b></td>
<td><b>FORMAT</b></td>
<td><b>DESCRIPTION</b></td>
<td><b>CREATED BY <b></td>
<td><b>SEE ALSO</b></td>
</tr>
<td><b>Domain hits file </b></td>
<td> DHF format (FASTA-like). </td>
<td> Database hits (sequences) with domain classification information.  The hits are relatives to a SCOP or CATH family (or other node in the structural hierarchies) and are found from a search of a discriminating element (e.g. a protein signature, hidden Markov model, simple frequency matrix, Gribskov profile or Hennikoff profile) against a sequence database. </td>
<td> <a href="seqsearch.html">SEQSEARCH</a> (hits retrieved by PSIBLAST). <a href="sigscan.html">SIGSCAN</a> (hits retrieved by sparse protein signature). <a href="libscan.html">LIBSCAN</a> (hits retrieved by various types of HMM and profile). </td>
<td> N.A. </td>
</tr>
<tr>
<td><b>Domain alignment file </b></td>
<td> DAF format (CLUSTAL-like). </td>
<td> Sequence alignment of domains belonging to the same SCOP or CATH family (or other node in the structural hierarchies).  The file is annotated with domain family classification information.</td>
<td> <a href="domainalign.html">DOMAINALIGN</a> (structure-based sequence alignment of domains of known structure). </td>
<td> DOMAINALIGN alignments can be extended with sequence relatives (of unknown structure) to the family in question by using SEQALIGN. </td>
</tr>
<tr>
<td><b> Hits file</b></td>
<td> Text file of classified hits </td>
<td> A list of hits (e.g. from a prediction method) that are classified and rank-ordered on the basis of score, p-value, E-value etc.  </td>
<td> <a href="rocon.html">ROCON</a> and <a href="libscan.html">LIBSCAN</a> (hits from searches of a discriminating element (hidden Markov model, profile or signature) against a sequence database).   </td>
<td> ROCPLOT is run on the files to perform Receiver Operator Characteristic (ROC) analysis on the hits.  </td>
</tr>
<tr>
<td><b>Signature file </b></td>
<td> SIG format </td>
<td> Contains a sparse sequence signature suitable for use with the SIGSCAN program. Contains a sparse sequence signature. </td>
<td> <a href="siggen.html">SIGGEN</a>, <a href="siggenlig.html">SIGGENLIG</a>, <a href="libgen.html">LIBGEN</a> </td>
<td> The files are generated by using SIGGEN. </td>
</tr>
</table>





None


<!-- DESCRIPTION
     A complete, non-technical, user-level description of the application.
-->
<a name="9.0"></a>
<br><br><br><H2> 9.0   DESCRIPTION               </H2>
See Blades et al., Ison et al. and Daniel et al. for a description of protein signatures and their application.


<!-- ALGORITHM
     A technical description of algorithmic aspects, describing exactly how
     the key aspects of the application work.
-->
<a name="10.0"></a>
<br><br><br><H2> 10.0  ALGORITHM                 </H2>
The algorithm is based on approach first described in Daniel et al (1999) that was applied to the definition of protein families (Ison et al, 2000) and later to automatically-generated signatures (Blades et al, 2005).



<!-- RELATED APPLICATIONS
     Other applications that either generate the input, use the output or 
     are in some other way related to the application are described here. 
-->

<a name="11.0"></a>
<br><br><br><H2> 11.0  RELATED APPLICATIONS      </H2>

<h2><a name="See also">See also</a></h2>
<table border cellpadding=4 bgcolor="#FFFFF0">
<tr><th>Program name</th><th>Description</th></tr>
<tr><td><a href="../../apps/contactcount.html">contactcount</a></td><td>Count specific versus non-specific contacts</td></tr>
<tr><td><a href="../structure/contacts.html">contacts</a></td><td>Generate intra-chain CON files from CCF files</td></tr>
<tr><td><a href="../domalign/domainalign.html">domainalign</a></td><td>Generate alignments (DAF file) for nodes in a DCF file</td></tr>
<tr><td><a href="../domalign/domainrep.html">domainrep</a></td><td>Reorder DCF file to identify representative structures</td></tr>
<tr><td><a href="../domainatrix/domainreso.html">domainreso</a></td><td>Remove low resolution domains from a DCF file</td></tr>
<tr><td><a href="../structure/interface.html">interface</a></td><td>Generate inter-chain CON files from CCF files</td></tr>
<tr><td><a href="libgen.html">libgen</a></td><td>Generate discriminating elements from alignments</td></tr>
<tr><td><a href="matgen3d.html">matgen3d</a></td><td>Generate a 3D-1D scoring matrix from CCF files</td></tr>
<tr><td><a href="../../apps/psiphi.html">psiphi</a></td><td>Phi and psi torsion angles from protein coordinates</td></tr>
<tr><td><a href="rocon.html">rocon</a></td><td>Generates a hits file from comparing two DHF files</td></tr>
<tr><td><a href="rocplot.html">rocplot</a></td><td>Performs ROC analysis on hits files</td></tr>
<tr><td><a href="../reconstruct/scorecmapdir.html">scorecmapdir</a></td><td>Contact scores for cleaned protein chain contact files</td></tr>
<tr><td><a href="../domalign/seqalign.html">seqalign</a></td><td>Extend alignments (DAF file) with sequences (DHF file)</td></tr>
<tr><td><a href="../domsearch/seqfraggle.html">seqfraggle</a></td><td>Removes fragment sequences from DHF files</td></tr>
<tr><td><a href="../domsearch/seqsearch.html">seqsearch</a></td><td>Generate PSI-BLAST hits (DHF file) from a DAF file</td></tr>
<tr><td><a href="../domsearch/seqsort.html">seqsort</a></td><td>Remove ambiguous classified sequences from DHF files</td></tr>
<tr><td><a href="../domsearch/seqwords.html">seqwords</a></td><td>Generates DHF files from keyword search of UniProt</td></tr>
<tr><td><a href="siggen.html">siggen</a></td><td>Generates a sparse protein signature from an alignment</td></tr>
<tr><td><a href="siggenlig.html">siggenlig</a></td><td>Generate ligand-binding signatures from a CON file</td></tr>
<tr><td><a href="sigscanlig.html">sigscanlig</a></td><td>Search ligand-signature library & write hits (LHF file)</td></tr>
</table>




<!-- DIAGNOSTIC ERROR MESSAGES
     Description of error messages or log file, if one is written.
-->
<a name="12.0"></a>
<br><br><br><H2> 12.0  DIAGNOSTIC ERROR MESSAGES </H2>
None.



<!-- AUTHORS
     The main author first then all others. 
-->
<a name="13.0"></a>
<br><br><br><H2> 13.0  AUTHORS                   </H2>
Jon Ison <a href="mailto:jison@rfcgr.mrc.ac.uk">(jison@rfcgr.mrc.ac.uk)</a>
<br>
MRC Rosalind Franklin Centre for Genomics Research
Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1SB, UK




<!-- REFERENCES
     Quote the paper where the application was first published, described, used etc. 
-->
<a name="14.0"></a>
<br><br><br><H2> 14.0  REFERENCES                </H2>
Please cite the authors and EMBOSS.
<br><br>
<i>Rice P, Longden I and Bleasby A (2000) "EMBOSS - The European
Molecular Biology Open Software Suite"  Trends in Genetics,
15:276-278.

<p>
See also <a href="http://emboss.sourceforge.net/">http://emboss.sourceforge.net/</a></i>



Automatic generation and evaluation of sparse protein signatures for families of protein 
structural domains. MJ Blades, JC Ison, R Ranasinghe, and JBC Findlay. Protein Science. 2005 (accepted)

<br><br>
A key residues approach to the definition of protein families and analysis
of sparse family signatures.  JC Ison, AJ Bleasby, MJ Blades, SC Daniel, 
JH Parish, JBC Findlay.  PROTEINS: Structure, Function & Genetics.  2000, 
40:330-341
<br><br>
Alignment of a sparse protein signature with protein sequences: application
to fold prediction for three small globulins.  SC Daniel, JH Parish, 
JC Ison, MJ Blades & JBC Findlay.  FEBS Letters.  1999, 459:349-352. 





<H3>14.1 Other useful references  </H3>


</BODY>
</HTML>



